|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-9-10
|
|
pubmed:abstractText |
Interferon beta-1a (IFNbeta-1a, Avonex) is efficacious in relapsing forms of MS. Studies of other IFNbeta preparations in secondary progressive MS (SPMS) yielded conflicting results. This study was undertaken to determine whether IFNbeta-1a slowed disease progression in SP-MS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
pubmed-author:CohenJ AJA,
pubmed-author:CutterG RGR,
pubmed-author:FischerJ SJS,
pubmed-author:GoodmanA DAD,
pubmed-author:HeidenreichF RFR,
pubmed-author:IMPACT Investigators,
pubmed-author:KooijmansM FMF,
pubmed-author:RudickR ARA,
pubmed-author:SOHRCC,
pubmed-author:SandrockA WAW,
pubmed-author:SimonJ HJH,
pubmed-author:SimonianN ANA,
pubmed-author:WhitakerJ NJN
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
10
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
679-87
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12221157-Adjuvants, Immunologic,
pubmed-meshheading:12221157-Adult,
pubmed-meshheading:12221157-Disability Evaluation,
pubmed-meshheading:12221157-Double-Blind Method,
pubmed-meshheading:12221157-Female,
pubmed-meshheading:12221157-Follow-Up Studies,
pubmed-meshheading:12221157-Humans,
pubmed-meshheading:12221157-Interferon-beta,
pubmed-meshheading:12221157-Magnetic Resonance Imaging,
pubmed-meshheading:12221157-Male,
pubmed-meshheading:12221157-Middle Aged,
pubmed-meshheading:12221157-Multiple Sclerosis, Chronic Progressive,
pubmed-meshheading:12221157-Quality of Life,
pubmed-meshheading:12221157-Recurrence,
pubmed-meshheading:12221157-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
|
|
pubmed:affiliation |
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, OH 44195, USA. cohenj@ccf.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
